Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 11, 2007, Pages 1202-1208

  Vucic, Steve ^b   Krishnan, Arun V ^b   Kiernan, Matthew C ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; HYPERPOLARIZATION; MALE; MOTOR NEURON DISEASE; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; NERVE EXCITABILITY; PRIORITY JOURNAL; STIMULUS RESPONSE; WEAKNESS; CELL MEMBRANE POTENTIAL; ELECTROSTIMULATION; INNERVATION; MEDIAN NERVE; MIDDLE AGED; MOTONEURON; MUSCLE FATIGUE; MUSCLE ISOMETRIC CONTRACTION; NERVE FIBER; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REACTION TIME; REFERENCE VALUE; SIGNAL PROCESSING; SKELETAL MUSCLE;

ADULT; AGED; AXONS; ELECTRIC STIMULATION; FATIGUE; FEMALE; HUMANS; ISOMETRIC CONTRACTION; MALE; MEDIAN NERVE; MEMBRANE POTENTIALS; MIDDLE AGED; MOTOR NEURON DISEASE; MOTOR NEURONS; MUSCLE FATIGUE; MUSCLE, SKELETAL; NEUROLOGIC EXAMINATION; REACTION TIME; REFERENCE VALUES; SENSORY THRESHOLDS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 35748955508     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.112078     Document Type: Article

References (53)

1. Desai J, Swash M. Essentials of diagnosis. London: WB Saunders, 2002:1-21.
2. Kiernan MC. Motor neurone disease: a Pandora's box. Med J Aust 2003;178:311-12.
3. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-700.
4. Aimer G, Vukosavic S, Romero N, et al. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999;72:2415-25.
5. Rothstein JD, Jin L, Dykes-Hoberg M, et al. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 1993;90:6591-5.
6. Trotti D, Rolfs A, Danbolt NC, et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 1999;2:848.
7. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
8. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:1424-37.
9. Crow JP, Sampson JB, Zhuang Y, et al. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 1997;69:1936-44.
10. Andrus PK, Fleck TJ, Gurney ME, et al. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1998;71:2041-8.
11. Sanjak M, Brinkmann J, Beiden DS, et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci 2001;191:55-9.
12. Sharma KR, Kent-Braun JA, Majumdar S, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 1995;45:733- 40.
13. Thomas CK, Zijdewind I. Fatigue of muscles weakened by death of motoneurons. Muscle Nerve 2006;33:21-41.
14. Carpentier A, Duchateau J, Hainaut K. Motor unit behaviour and contractile changes during fatigue in the human first dorsal interosseus. J Physiol (Lond) 2001;534:903-12.
15. Feasson L, Camdessanche JP, El Mhandi L, et al. Fatigue and neuromuscular diseases. Ann Readapt Med Phys 2006;49:375-84.
16. Robbins RA, Simmons Z, Bremer BA, et al. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442-4.
17. Vagg R, Mogyoros I, Kiernan MC, et al. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J Physiol (Lond) 1998;507:919-25.
18. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001;112:1575-85.
19. Bostock H, Grafe P. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J Physiol (Lond) 1985;365:239-57.
20. Bostock H, Bergmans J. Post-tetanic excitability changes and ectopic discharges in a human motor axon. Brain 1994;117:913-28.
21. Morita K, David G, Barrett JN, et al. Posttetanic hyperpolarization produced by electrogenic Na(+)-K+ pump in lizard axons impaled near their motor terminals. J Neurophysiol 1993;70:1874-84.
22. Kiernan MC, Lin CS, Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol (Lond) 2004;558:341-9.
23. Cappelen-Smith C, Kuwabara S, Lin CS, et al. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 2000;48:826-32.
24. Kaji R, Bostock H, Kohara N, et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000;123:1602-11.
25. Nodera H, Bostock H, Izumi Y, et al. Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test. Neurology 2006;67:280-7.
26. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
27. Lacomblez L, Bensimon G, Leigh PN, et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-31.
28. Zoing MC, Burke D, Pamphlett R, et al. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002). J Clin Neurosci 2006;13:78-83.
29. Kiernan MC. Riluzole: a glimmer of hope in the treatment of motor neurone disease. Early experience confirms that riluzole improves survival and is well tolerated. Med J Aust 2005;182:319-20.
30. Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25.
31. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
32. Medical Research Council. Aid to the examination of the peripheral nervous system, 1 vol. London: Her Majesty's Stationary Office, 1976.
33. Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605-11.
34. Vucic S, Howells J, Trevillion L, et al. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006;33:477-86.
35. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006;129:2436-46.
36. de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000;23:344-52.
37. Kiernan MC, Burke D, Andersen KV, et al. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409.
38. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-58.
39. Weiss G. Sur la possibilité de rendre comparables entre eux les appareils servant l'excitation électrique. Arch Ital Biol 1901;35:413-46.
40. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996;119:439-47.
41. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol (Lond) 1982;323:117-44.
42. David G, Modney B, Scappaticci KA, et al. Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J Physiol (Lond) 1995;489:141-57.
43. Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601-9.
44. Mogyoros I, Kiernan MC, Burke D, et al. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998;121:851-9.
45. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol (Lond) 1997;498:277- 94.
46. Rakowski RF, Gadsby DC, De Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon. J Gen Physiol 1989;93:903-41.
47. Bergmans J. The physiology of single human nerve fibres. Louvain: Vander, 1970.
48. Kiernan MC, Mogyoros I, Hales JP, et al. Excitability changes in human cutaneous afferents induced by prolonged repetitive axonal activity. J Physiol (Lond) 1997;500:255-64.
49. Kaji R, Sumner AJ. Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 1989;39:1364-8.
50. Vollestad NK, Sejersted OM, Bahr R, et al. Motor drive and metabolic responses during repeated submaximal contractions in humans. J Appl Physiol 1988;64:1421-7.
51. Ellis DZ, Rabe J, Sweadner KJ. Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2003;23:43-51.
52. 2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991;30:375-80.
53. Mogyoros I, Kiernan MC, Burke D, et al. Ischemic resistance of cutaneous afferents and motor axons in patients with amyotrophic lateral sclerosis. Muscle Nerve 1998;21:1692-700.